Nontoxic doses of suramin enhance activity of doxorubicin in prostate tumors.

Nontoxic doses of suramin enhance activity of doxorubicin in prostate tumors.

Item
http://www.wikidata.org/entity/Q43767983
Phase I trial of non-cytotoxic suramin as a modulator of docetaxel and gemcitabine therapy in previously treated patients with non-small cell lung cancer.Basic fibroblast growth factor impact on retinoblastoma progression and survivalBladder tissue pharmacokinetics of intravesical mitomycin C and suramin in dogsPharmacodynamics of telomerase inhibition and telomere shortening by noncytotoxic suramin.Suramin inhibits renal fibrosis in chronic kidney disease.The beneficial effect of suramin on monocrotaline-induced pulmonary hypertension in ratsPhase I/II trial of non-cytotoxic suramin in combination with weekly paclitaxel in metastatic breast cancer treated with prior taxanesThe FGF family: biology, pathophysiology and therapyNoncytotoxic suramin as a chemosensitizer in patients with advanced non-small-cell lung cancer: a phase II study.Metabotropic glutamate receptor 1 disrupts mammary acinar architecture and initiates malignant transformation of mammary epithelial cells.A combination treatment with DNA methyltransferase inhibitors and suramin decreases invasiveness of breast cancer cellsGlutamatergic pathway targeting in melanoma: single-agent and combinatorial therapies.Lysyl oxidase propeptide inhibits prostate cancer cell growth by mechanisms that target FGF-2-cell binding and signaling.
P2860

Nontoxic doses of suramin enhance activity of doxorubicin in prostate tumors.

Item
http://www.wikidata.org/entity/Q43767983
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Nontoxic doses of suramin enhance activity of doxorubicin in prostate tumors.
@en
Nontoxic doses of suramin enhance activity of doxorubicin in prostate tumors.
@nl
type
label
Nontoxic doses of suramin enhance activity of doxorubicin in prostate tumors.
@en
Nontoxic doses of suramin enhance activity of doxorubicin in prostate tumors.
@nl
prefLabel
Nontoxic doses of suramin enhance activity of doxorubicin in prostate tumors.
@en
Nontoxic doses of suramin enhance activity of doxorubicin in prostate tumors.
@nl
P1433
P1476
P2093
P304
P31
P407
P433
P478
P577
P698
P1433
P1476
Nontoxic doses of suramin enhance activity of doxorubicin in prostate tumors
@en
P2093
P304
P31
P407
P433
P478
P577
P698